Skip to main content

Itching

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Auricular acupressureN/A1 trial
Active Trials
NCT06323304CompletedEst. Aug 2024
Orion Pharma
Orion PharmaUK - Reading
1 program
Remo-Wax® OilN/A1 trial
Active Trials
NCT05811039Completed36Est. Oct 2023
Orion
OrionUK - Cambridge
1 program
Remo-Wax® OilN/A

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
City TherapeuticsAuricular acupressure
Orion PharmaRemo-Wax® Oil

Clinical Trials (2)

Total enrollment: 36 patients across 2 trials

NCT06323304City TherapeuticsAuricular acupressure

Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis

Start: Mar 2024Est. completion: Aug 2024
N/ACompleted

Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal

Start: May 2023Est. completion: Oct 202336 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.